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Sleep is a state resulting from the interaction between phys-
iological and behavioral factors. Quantity and quality of 
sleep represent important factors for the quality of life, 
which can have positive or negative influence on individual 
health.1-3 The assessment of the risks and benefits associ-
ated with a particular life style is a precondition to modify-
ing habits that are responsible for the development of 
pathological processes.
Evidence exists that sleep disorders are associated with 
an increased risk of cancer. For instance, shift workers show 
an increased risk of numerous cancers.4-8 On the other hand, 
the diagnosis of cancer and/or cancer therapies are often 
associated with fatigue and depression that can exacerbate a 
preexisting sleep disorder or contribute to initiating one. 
Breast cancer (BC) is the most common malignancy in 
women, and it is the main cause of death from women’s 
cancer. BC survivors are constantly increasing, and research 
investments to identify modifiable factors associated with 
BC recurrences are increasing too. Elucidation of the 
651719 ICTXXX10.1177/1534735416651719Integrative Cancer TherapiesRoveda et al
research-article2016
1Department of Biomedical Sciences for Health, University of Milan, 
Milan, Italy
2Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
3IRCCS Policlinico San Donato Milanese, Milan, Italy
Corresponding Author:
Eliana Roveda, Department of Biomedical Sciences for Health, University 
of Milan, Via Giuseppe Colombo 71, Milano 20133, Italy. 
Email: eliana.roveda@unimi.it
Protective Effect of Aerobic Physical  
Activity on Sleep Behavior in Breast  
Cancer Survivors
Eliana Roveda, MD, PhD1, Jacopo A. Vitale, MSc1, Eleonora Bruno, MSc1,2,  
Angela Montaruli, PhD1, Patrizia Pasanisi, MD2, Anna Villarini, PhD2,  
Giuliana Gargano, PhD2, Letizia Galasso, MSc1, Franco Berrino, MD2,  
Andrea Caumo, MSc1,3, and Franca Carandente, MD1
Abstract
Hypotheses. Sleep disorders are associated with an increased risk of cancer, including breast cancer (BC). Physical activity 
(PA) can produce beneficial effects on sleep. Study design. We designed a randomized controlled trial to test the effect of 
3 months of physical activity on sleep and circadian rhythm activity level evaluated by actigraphy. Methods. 40 BC women, 
aged 35-70 years, were randomized into an intervention (IG) and a control group (CG). IG performed a 3 month of aerobic 
exercise. At baseline and after 3 months, the following parameters were evaluated both for IG and CG: anthropometric 
and body composition measurements, energy expenditure and motion level; sleep parameters (Actual Sleep Time-AST, 
Actual Wake Time-AWT, Sleep Efficiency-SE, Sleep Latency-SL, Mean Activity Score-MAS, Movement and Fragmentation 
Index-MFI and Immobility Time-IT) and activity level circadian rhythm using the Actigraph Actiwatch. Results. The CG 
showed a deterioration of sleep, whereas the IG showed a stable pattern. In the CG the SE, AST and IT decreased and the 
AWT, SL, MAS and MFI increased. In the IG, the SE, IT, AWT, SL, and MAS showed no changes and AST and MFI showed 
a less pronounced change in the IG than in the CG. The rhythmometric analysis revealed a significant circadian rhythm in 
two groups. After 3 months of PA, IG showed reduced fat mass %, while CG had improved weight and BMI. Conclusion. 
Physical activity may be beneficial against sleep disruption. Indeed, PA prevented sleep worsening in IG. PA can represent 
an integrative intervention therapy able to modify sleep behaviour.
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relationships between sleep quality and cancer is thus of 
interest both in prevention of the primary pathology as well 
as in the prevention of potential recurrences.
Physical activity (PA) is one of the lifestyle-related factors 
that are decisive for the quality of sleep.9-13 The relationship 
between sleep and PA has been actively investigated in the 
past, and several studies have shown that engaging in regular 
physical exercise can produce beneficial effects on nighttime 
sleep.9,10,14 Certainly, PA reduces body weight, insulin resis-
tance,15 and inflammation,13,16,17 which are all important fac-
tors related to sleep. Extensive research has been conducted 
to evaluate the positive impact of exercise after BC diagno-
sis. These studies provided support for reduced mortality 
from this disease among women who engage in moderate 
PA.18-25 However, few studies26,27 have evaluated the effect of 
a structured program of aerobic PA on nocturnal sleep by 
using actigraphy. Mustian et al26 demonstrated that 4 weeks 
of yoga is a useful therapy for posttreatment cancer survivors 
with impaired sleep, improving sleep quality; significant 
improvements have been demonstrated with respect to global 
sleep quality, sleep latency, sleep duration, sleep efficiency. 
Payne et al27 suggest that a prescribed home-based walking 
exercise intervention may improve sleep in older women 
receiving hormonal treatment for BC. It stands to reason that 
the practice of a regular PA in women with BC can help regu-
larize the sleep-wake cycle and improve nocturnal sleep.
The aim of this randomized controlled trial was to evalu-
ate the effect of an aerobic PA program on sleep behavior in 
BC survivors. If PA is able to act positively on sleep, this 
finding would strengthen the importance of exercise in the 
integrated treatment of cancer. Actigraphy, which offers one 
of the best-known alternatives to polysomnography, was 
used to derive sleep parameters.28-32
Materials and Methods
Subjects
The women included in this study belong to the Diet and 
Androgen-5 study (DIANA-5),33,34 an ongoing multi- 
institutional randomized controlled trial aiming to test the 
hypothesis that a dietary change based on the Mediterranean 
diet and macrobiotic principles, together with moderate PA, 
can reduce the incidence of additional BC-related events in 
women with BC. Inclusion criteria in DIANA-5 study were 
as follows:
•• mastectomy or conservative surgery for primary 
invasive BC, any type, within the previous 5 years
•• no history or objective evidence of recurrent disease 
or metachronous ipsilateral or contralateral BC
•• 35 to 70 years of age at recruitment
•• not scheduled for and not currently undergoing 
chemotherapy
•• no other cancer diagnosis within the last 10 years
•• no comorbidity requiring a specific diet or contrain-
dicating a high-fiber diet, moderate calorie restric-
tion, or physical exercise
•• no medical or social condition that would interfere 
with participation in a 5-year diet and physical exer-
cise study
•• able to fill-in self-administered questionnaires
In February 2014, 42 women with BC belonging to the 
intervention arm of the DIANA-5 study agreed to partici-
pate in the present study (see the Statistical Analysis sec-
tion for a description of the power analysis carried out to 
choose the sample size). In addition to the inclusion criteria 
mentioned above, the women had no family or working 
impediment that could preclude participation in the PA pro-
gram. All women had participated in DIANA-5 for at least 
2 years and received the same dietary recommendations 
and activities.
Women were randomized in the intervention group (IG) 
or the control group (CG). Since 2 women of IG dropped 
out because of medical problems, the IG was composed of 
19 subjects while the CG had 21. The dropouts in the IG 
occurred before the beginning of the PA program.
The mean age (± SD) at study entry was similar for both 
groups with no statistical differences: 55.2 (± 6.8) years for 
the IG and 58.2 (± 6.4) years for the CG.
Women in the CG received only the WCRF/AICR rec-
ommendation to be physically active for at least 30 minutes 
every day. Women in the IG received the same recommen-
dations, but were also requested to participate in a 3-month 
active PA program that included 2 sessions of 1-hour brisk 
walking per week. During the 3 months of the trial program 
all women, both IG and CG, continued to participate in the 
DIANA-5 study activities including cooking classes and 
nutritional advice. An informed consent document was 
obtained from each participant before the beginning of the 
intervention, and all risks and benefits of the study were 
explained. The study was approved by the Ethical Review 
Board of the National Cancer Institute of Milan (Italy).
Physical Activity intervention
Women included in the IG attended a program of aerobic 
PA over a period of 3 months, from the first week of March 
to the last week of May 2014. The PA program was con-
ducted by 2 sport therapy experts and included 2 sessions of 
1-hour brisk walking per week, on Wednesday and Friday. 
Each training session also included 10 minutes of cool-
down of static stretching at the end of the walking. Data 
about the attendance to the training were collected each day 
before the training started. At the beginning of the physical 
tasks, each subject wore the heart rate monitor (Polar s810, 
Polar Electro Oy, Kempele, Finland), set to record the 
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beat-to-beat interval of every heartbeat. The heart rate data 
collected during the walking sessions were downloaded to 
the Polar Precision Performance software 3.0. The mean 
heart rate (HRmean) of each participant was studied through 
descriptive analysis. The IG performed an aerobic PA since 
the range of the HRmean of the group was 58% to 73% with 
a mean group of 68% of the maximum heart rate. The adher-
ence to PA was 86.8 ± 4.9% (expressed as percentage of the 
total numbers of training sessions). The IG PA sessions 
were carried out on fixed days and times with the same 
trainer during 3 months.
At baseline (last week of February/PRE) and at the end 
(first week of June/POST) of the 3-month PA program, both 
groups underwent an anthropometric and body composition 
evaluation, an actigraph-based monitoring of sleep and 
activity-level parameters, and an armband-based monitor-
ing of motion-level parameters.
Anthropometric and Body Composition 
Evaluation
Anthropometric and body composition measurements (per-
centages of fat mass and lean mass) were taken using a body 
segmental impedance balance, Tanita BC-418 (Body 
Composition Analyzer BC-41 AM, Tanita Corporation, 
Tokyo, Japan). Waist circumference was measured with a 
measuring tape in the midpoint between the lowest rib and 
the iliac crest during exhale.
Actigraphic Monitoring of Sleep Patterns
The subjects wore the Actigraph Actiwatch (Cambridge 
Neurotecnology, Cambridge, UK) for 1 week (from Monday 
to Sunday) on the nondominant hand for the evaluation of 
sleep parameters, both at baseline and after 3 months of PA. 
We used a low actigraphic sensitivity threshold (80 counts 
per epoch). Together with the actigraph, each subject 
received a diary to record the information about bed time, 
wake up time, hours of naps, hours without wearing the acti-
graph, and number of nocturnal awakenings. The data 
recorded by the actigraph were analyzed by the Actiwatch 
Sleep Analysis Software with the aim of deriving parameters 
capable to quantify the quantity and quality of sleep. Data 
analysis started with the onset of nocturnal rest (bedtime) 
and ended with the onset of daytime activity (wake time). 
Exact bedtimes and waking times were set for each subject 
using information from the rest-activity pattern and diary. 
The software yielded the following sleep parameters.
Actual Sleep Time (AST). The amount of time between 
Sleep Start and Sleep End. This is determined by the sum-
mation of the number of epochs that do not exceed the 
sensitivity threshold and multiplying that value by the 
epoch length in min.
Actual Wake Time (AWT). The total time spent awake accord-
ing to the epoch-by-epoch wake/sleep categorization.
Sleep Efficiency (SE). The percentage of time in bed actually 
spent sleeping.
Sleep Latency (SL). The period of time required for sleep 
onset after retiring to bed. SL is the period between Bed 
Time and Sleep Start. This is automatically calculated by 
an algorithm, based on lack of movement following Bed 
Time.
Immobility Time (IT). The total time, expressed in percent-
age, spent without recording any movement within the 
period of Sleep Start and Sleep End.
Mean Activity Score (MAS). It represents the average activity 
score recorded between Sleep Start and Sleep End.
Movement and Fragmentation Index (MFI). The addition of 
the Movement Index (percentage time spent moving) and 
the Fragmentation Index (percentage of immobile phases 
of one minute). MFI is used as an index of restlessness.
Actigraphic Monitoring of Activity Level and 
Circadian Rhythm
The data recorded by the actigraph were analyzed using 
Actiwatch Activity Analysis software to obtain the activity 
data for all women at baseline and after 3 months. These 
data were used to evaluate the activity-level circadian 
rhythm for each subject. A parametric portrait of the circa-
dian rhythm was obtained consisting of 3 parameters:
MESOR (M). This represents the mean activity for a 
24-hour period.
Amplitude (A). This measures one half the extent of the 
rhythmic variation in a cycle.
Acrophase (φ). This measures the time interval within 
which the highest values of activity are expected.
Armband-Based Monitoring of Energy 
Expenditure
The SenseWear Pro 3 Armband (Body-Media, Pittsburgh, 
USA) was used to collect data on energy expenditure (EE) 
and motion level.35-37 All women wore the device for 1 week 
on the right upper arm over the triceps muscle. All patients 
were instructed to continuously wear the Armband for an 
average of 7 consecutive days except during water-based 
activities. Algorithms provided by the manufacturer combine 
the sensor data with age, body weight, height, gender, smok-
ing status, and handedness to produce minute-by-minute esti-
mates of Total Energy Expenditure and to quantify, with 
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selectable thresholds of Metabolic Equivalents, daily motion 
level.
The armband provided the following metabolic and 
motion level parameters:
•• Total Energy Expenditure (TEE)
•• Numbers of steps per day
•• Metabolic Equivalent (MET = 1 kcal/kg/h)
•• Physical Activity Level (PAL = TEE/REE), where 
REE is the Rest Energy Expenditure
Daily targets PAL ≥ 1.7 were used to classify subjects as 
physically active or not. The SenseWear software estimates 
Physical Activity Duration (PAD) spent for a specific period 
above a set threshold in METs. Usually, the threshold value 
of 3.0 METs is an acceptable value of the minimum activity 
(by sedentary lifestyle), which is the equivalent of a brisk 
walk.
Statistical Analysis
Unless otherwise stated, the statistical analyses were con-
ducted using SPSS version 21 software (IBM Corporation, 
Armonk, NY), and a P value less than or equal to .05 was 
considered statistically significant. Below we describe the 
power analysis carried out to choose the sample size of the 
study, as well as the statistical analyses of sleep, rhythmo-
metric, anthropometric, and motion-level parameters.
Power Analysis for Determination of the Sample Size. In order 
to arrive at a reasonable sample size for each of the 2 groups 
participating in the study, we carried out a power analysis 
that focused on the ability of the study to detect changes in 
sleep efficiency, which is perhaps the most clinically mean-
ingful actigraphy-based sleep parameter. To perform the 
power analysis, we needed an estimation of the variability 
of Sleep Efficiency. In a previous investigation,3 we had 
found that Sleep Efficiency in normal subjects was about 84 
± 5% (mean ± SD), and thus we set SD = 5%. We decided 
that the magnitude of the clinical difference of interest in 
Sleep Efficiency between the PRE and POST conditions (ie, 
the smallest effect that we wanted to be able to detect) was 
in the range 3% to 4%. By setting the power (1 − β) to .80 
and the significance level α to .05 (2-tailed), we found that 
the sample size of each group had to be between 14 and 24 
subjects (calculations were carried using the sample size 
calculator developed by Russel Lenth and available at 
http://www.stat.uiowa.edu/~rlenth/Power). We finally set 
the sample size to 21 subjects per group.
Analysis of Sleep Parameters. Sleep behavior was described 
by 7 actigraphy-based sleep parameters (AST, AWT, SE, 
SL, IT, MAS, and MFI). Each parameter was evaluated 
twice (pretest and posttest) in both groups (intervention and 
control). The parameter results were expressed as mean ± 
SD. The distribution of each parameter in the pretest and 
posttest conditions was tested for normality by graphical 
methods and the Shapiro-Wilk’s test. All the parameters 
were normally distributed with the exception of SL and IT. 
In order to test the null hypothesis for no difference between 
the pretest scores of the control and intervention groups, SL 
and IT were subjected to the nonparametric Mann-Whitney 
rank test, whereas AST, AWT, SE, MAS, and MFI were 
subjected to the unpaired Student’s t test. SL and IT were 
then subjected to the Wilcoxon paired-sample test to test the 
null hypothesis for no difference between the pretest and 
posttest scores, whereas the 5 sleep parameters displaying 
normal distribution (AST, AWT, SE, MAS, and MFI) were 
subjected to repeated-measures multivariate analysis of 
variance (RM-MANOVA) to test whether there was an 
overall change of sleep behavior over time between the 
intervention and control groups. Before running RM-
MANOVA, a correlation-matrix analysis was carried out to 
ascertain the degree of correlation between each pair of 
dependent variables. We found that AWT and SE were 
highly and negatively correlated (Pearson’s r = −0.82 in 
both the pretest and posttest conditions) and AWT and MAS 
were highly and positively correlated (r = 0.81 and r = 0.85 
in the pretest and posttest conditions, respectively). In order 
to avoid multicollinearity, the offending variable AWT was 
removed from RM-MANOVA and was subjected to a mixed 
ANOVA characterized by one within-subjects factor (time, 
with 2 levels: pretest and posttest) and one between-sub-
jects factor (group, with 2 levels: intervention and control). 
The purpose of the 2-way repeated-measures ANOVA was 
to establish whether AWT differed between the 2 groups 
over time and whether there was an interaction between 
group and time. The set of the other 4 dependent variables 
(AST, SE, MAS, and MFI) was subjected to RM-MANOVA 
(within-subjects factor: time; between-subjects factor: 
group). RM-MANOVA provided both a multivariate effect 
and a set of univariate effects. The multivariate effect quan-
tified the overall impact that group, time, and their interac-
tion had on sleep behavior (described by that linear 
combination of the dependent variables providing the best 
separation between the groups and the time points). The 
univariate effects quantified how much the mean value of 
each dependent variable differed across groups and time 
points. Within each univariate effect, the interaction 
between group and time was also evaluated. The presence 
of a significant interaction indicated that the modality of 
change of the sleep parameter over time (from the pretest to 
the posttest) depended on the group. When the univariate 
analysis showed a significant interaction, the mean of the 
dependent variable was compared across time points by 
performing 2 paired Student’s t tests, one for the control 
group and one for the intervention group. In each case, cut-
off levels for statistical significance were adjusted 
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according to Bonferroni’s correction to account for multiple 
comparisons (cutoff = 0.05/2 = 0.025).
Rhythmometric Analysis of Activity. To evaluate the activity-
level circadian rhythm, we analyzed the activity data using 
single cosinor method.38,39 Hinging on the least-squares 
method, the single cosinor method identifies and evaluates 
the cosine mathematical function that best fits the data as a 
function of time. The function, f(t) = M + A cos(ωt + φ), 
defines 3 parameters characteristic of each statistically sig-
nificant rhythm: M is the MESOR; A is the amplitude; φ is 
the acrophase. MESOR (Midline Estimating Statistic of 
Rhythm) is a rhythm-adjusted mean that approximates the 
arithmetical mean of the data for a 24-hour period, and 
amplitude is the measure of one half of extent of the rhyth-
mic variation in a cycle. Acrophase indicates, with its 95% 
confidence limits (CL), the time interval within which the 
highest values of activity are expected. The 3 parameters are 
usually indicated with the relevant 95% confidence inter-
vals. Each parameter was evaluated twice (pretest and post-
test) in both groups (intervention and control). The 
rhythmometric parameters of activity levels (MESOR, 
Amplitude, and Acrophase) were then processed with the 
average of population mean cosinor. This method, applied to 
the rhythmometric parameters of each subject’s circadian 
variables, evaluates the rhythmometric characteristics of the 
activity levels of the population and provides a significant P 
value (P < .05) when a circadian rhythm is present.39 The 
rhythmometric analysis was carried out with Time Series 
Analysis-Seriel Cosinor 6.0 by Expert Soft Technologie.
The statistical analysis of the rhythmometric parameters 
(MESOR, Amplitude, and Acrophase) followed the same 
rationale outlined above for the sleep parameters. The dis-
tribution of each parameter in the pretest and posttest condi-
tions was tested for normality by graphical methods and the 
Shapiro-Wilk’s test. No marked deviations from normality 
were detected, and the parameters were expressed as mean 
± SD. In order to test the null hypothesis for no difference 
between the pretest scores of the control and intervention 
groups, the parameters were subjected to the unpaired 
Student’s t test. Then, the 3 parameters were subjected to 
RM-MANOVA to test whether there was an overall change 
of circadian rhythmicity over time between the intervention 
and control groups. Before running RM-MANOVA, a cor-
relation-matrix analysis was carried out to ascertain the 
degree of correlation between each pair of dependent vari-
ables. We found that MESOR and amplitude were highly 
and positively correlated (r = −0.93 in both the pretest and 
posttest conditions). In order to avoid multicollinearity, 
MESOR was removed from RM-MANOVA and was sub-
jected to a mixed ANOVA. Finally, RM-MANOVA was 
carried out on a set of 2 dependent variables (Amplitude 
and Acrophase). RM-MANOVA provided both a multivari-
ate effect and a set of univariate effects that were evaluated 
using the same approach as discussed above for the sleep 
parameters.
Analysis of Anthropometric and Motion-Level Parameters. The 
anthropometric parameters (weight, body mass index 
[BMI], waist circumference, fat mass, lean mass) and the 
motion-level parameters (TEE, number of steps, METs 
average, and PAL) were analyzed as follows. Each param-
eter was evaluated twice (pretest and posttest) in both 
groups (intervention and control). The distribution of each 
parameter in the pretest and posttest conditions was tested 
for normality by graphical methods and the Shapiro-Wilk’s 
test. All the parameters were normally distributed and were 
expressed as mean ± SD. In order to test the null hypothesis 
for no difference between the pretest scores of the control 
and intervention groups, the parameters were subjected to 
the unpaired Student’s t test. To test the null hypothesis for 
no difference between the pretest and posttest scores for no 
difference across time points, 2 paired Student’s t tests 
were performed, one for the control group and one for the 
intervention group. In each case, cutoff levels for statistical 
significance were adjusted according to Bonferroni’s cor-
rection to account for multiple comparisons (cutoff = 
0.05/2 = 0.025).
We investigated the correlation between anthropometric, 




Table 1 shows the sleep parameters measured at baseline 
(PRE) and after 3-months (POST) in the intervention group 
(IG) and in the control group (CG). Figure 1 allows a visual 
appreciation of the trajectories of the sleep parameters in 
the 2 groups from PRE to POST. Three out of 7 parameters 
(ie, SE, AST, IT) are representative for restful sleep (the 
higher the parameter, the better). The other 4 parameters (ie, 
MAS, AWT, MFI, SL) are representative for fragmented 
sleep (the lower the parameter, the better). The presence of 
an interaction between group and time is visualized as 2 
nonparallel lines (one line per group) connecting the levels 
of the sleep parameter measured at the 2 time points (PRE 
and POST).
Prior to the beginning of the experimental protocol, IG 
and CG were comparable for all the sleep parameters (no 
significant differences were observed in the sleep parame-
ters of the 2 groups in the PRE condition).
The Wilcoxon test showed that differences between the 
PRE and POST levels of parameters SL and IT were not sta-
tistically significant in the IG, but were statistically signifi-
cant in the CG (P = .046 for SL and P < .001 for IT). The 
mixed ANOVA performed on parameter AWT showed a 
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statistically significant interaction between time and group 
(F[1, 38] = 6.7, P = .014), indicating that the changes dis-
played by this parameter differed between the 2 groups from 
PRE to POST. The source of such interaction was examined 
by performing 2 paired Student’s t tests with Bonferroni’s 
correction of the significance level (α = 0.05/2 = 0.025). We 
found that AWT increased significantly in the CG (P = .002) 
from PRE to POST, but remained unchanged in the IG.
The multivariate outcome of RM-MANOVA showed the 
presence of a significant interaction between time and group 
(Pillai’s trace = 2.33, F[4, 35] = 2.81, P = .04), indicating 
that the 2 groups exhibited a different pattern of change of 
sleep behavior across time. The univariate analyses showed 
a significant interaction between time and group for SE 
(F[1, 38] = 7.8, P = .008) and MAS (F[1, 38] = 9.2, P = 
.004), while AST came close to but did not achieve the 
Table 1. Sleep Parameters at Baseline (PRE) and After 3 Months (POST) for Intervention Group (IG) Versus Control Group (CG)a.
Parameters
IG CG
PRE POST Effect of Time PRE POST Effect of Time
SE (%) 84.4 ± 4.3 84.6 ± 4.9 ns 85.2 ± 5.2 80.7 ± 6.0 P < .001b
AST (minutes) 392.6 ± 42.4 386.1 ± 42.2 P = .03c 402.1 ± 37.5 374.1 ± 40.3 P = .03c
IT (%) 88.4 ± 3.5 87.1 ± 4.4 ns 87.8 ± 3.6 83.7 ± 5.3 P < .001d
MAS (counts) 17.7 ± 7.6 15.9 ± 6.8 ns 13.7 ± 5.2 19.2 ± 7.1 P < .001b
AWT (minutes) 55.6 ± 22.5 52.6 ± 20.5 ns 49.9 ± 20.4 60.3 ± 20.4 P = .002e
MFI 25.0 ± 7.1 27.4 ± 8.0 P = .02c 27.2 ± 9.4 31.7 ± 10.6 P = .02c
SL (minutes) 11.7 ± 11.1 15.4 ± 9.5 ns 15.7 ± 10.0 25.1 ± 18.5 P = .046d
Abbreviations: SE, sleep efficiency; AST, actual sleep time; IT, immobility time; MAS, mean activity score; AWT, actual wake time; MFI, Movement & 
Fragmentation Index; SL, sleep latency; ANOVA, analysis of variance; RM-MANOVA, repeated-measures multivariate analysis of variance.
aValues presented as mean ± SD. No significant differences were observed in the sleep parameters between IG and CG in the PRE condition. See the 
main text for details about the statistical analyses.
bRM-MANOVA followed by univariate analyses that found a significant interaction between group and time. The effect of time was assessed by using 
paired Student’s t tests with Bonferroni’s correction.
cRM-MANOVA followed by univariate analyses that found no interaction between group, but a significant effect of time.
dWilcoxon test.
eMixed ANOVA that found a significant interaction between group and time. The effect of time was assessed by using paired Student’s t tests with 
Bonferroni’s correction.
Figure 1. Visual appreciation of the trajectories of the sleep parameters in the IG and CG from PRE (baseline conditions) to POST 
(after 3 months). Three out of 7 parameters (ie, SE, AST, IT) are representative of Restful Sleep (the higher the parameter, the 
better). The other 4 parameters (ie, MAS, AWT, MFI, SL) are representative of Fragmented Sleep (the lower the parameter, the 
better). The presence of an interaction between group and time is visualized as 2 nonparallel lines (one line per group) connecting the 
levels of the sleep parameter measured at the 2 time points (PRE and POST). For the statistical analysis, refer to the text.
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statistical significance (P = .06). Both SE and MAS were 
then subjected to 2 paired Student’s t tests with Bonferroni’s 
correction of the significance level (α = 0.05/2 = 0.025) to 
determine the source of the interaction. We found that SE 
decreased significantly in the CG (P < .001) from PRE to 
POST, but remained unchanged in the IG, whereas MAS 
increased significantly in the CG (P < .001) from PRE to 
POST, but remained unchanged in the IG. The 2 parameters 
that did not achieve a significant interaction between time 
and group (ie, AST [P = .06] and MFI [P = .4]), neverthe-
less, displayed a significant main effect of time. AST 
showed a significant decrease from PRE to POST (F[1, 38], 
P = .03), while MFI showed a significant increase from 
PRE to POST (F[1, 38], P = .02). All these results indicate 
that the subjects of the CG showed a generalized deteriora-
tion of their sleep behavior, whereas the subjects of the IG 
maintained their sleep behavior more stable.
Activity-Level Circadian Rhythm
Table 2 reports the rhythmometric parameters measured in 
the IG and CG. The single cosinor method revealed the pres-
ence of a statistically significant activity level circadian 
rhythm (P < .001) in each one of the 40 women. The popula-
tion mean cosinor applied to the IG and CG, at baseline 
(PRE) and after 3 months (POST), revealed the presence of 
a significant circadian rhythm with in the 2 groups (P < 
.001). MESOR, Amplitude, and Acrophase were not differ-
ent in the 2 groups in the pretest condition. The mixed 
ANOVA carried out on MESOR showed no statistically sig-
nificant main effect for time and group, neither a statistically 
significant interaction between time and group, indicating 
that MESOR was virtually the same in the 2 groups and 
remained stable across time. RM-MANOVA showed a sta-
tistically significant effect of time (Pillai’s trace = 0.17, F[2, 
37] = 3.6, P = .04), but no interaction between time and 
group, indicating that the circadian rhythm (as portrayed by 
the linear combination of Amplitude and Acrophase) 
changed at virtually the same rate in the 2 groups between 
PRE and POST. The univariate analyses established that the 
only effect achieving statistical significance was the main 
effect of time on Amplitude, that decreased significantly 
between PRE and POST (F[1, 38] = 6.4, P = .02).
Anthropometric and Motion-Level Parameters
Table 3 shows the anthropometric and motion-level param-
eters measured at baseline (PRE) and after 3 months (POST) 
in the IG and CG. We ascertained that, prior to the begin-
ning of the experimental protocol, IG and CG were compa-
rable for all the anthropometric and motion-level parameters 
(no significant differences were found in anthropometric 
and motion-level parameters of the 2 groups in the PRE 
condition). Of note, prior to the beginning of the PA pro-
gram, both groups presented an inactive lifestyle (PAL < 1.7 
METs). Table 3 also reports the statistical assessment of the 
comparison between the PRE versus POST anthropometric 
and motion-level parameters in the 2 groups. After 3 months 
of PA, CG had significantly improved weight and BMI (P = 
.01). Only in the IG we observed a significant reduction in 
fat mass % (P = .02). No changes in the indices of motion 
level were found in IG and CG.
Relationship Between Sleep Parameters and 
Anthropometric and Motion-Level Parameters
At basal condition, in all 40 women, correlation analysis 
showed that SE was inversely and significantly correlated 
with fat mass percentage (r = −0.38, P < .05) and was 
directly correlated with lean mass percentage (r = +0.39, 
P < .05). SL was significantly and directly correlated with 
BMI (r = +0.34, P < .05) and body fat mass percentage 
(r = +0.35, P < .05) and inversely correlated with lean 
mass percentage (r = −0.33, P < .05). MFI was signifi-
cantly and inversely correlated with the number of steps 
(r = −0.32, P < .05).
Table 2. Rhythmometric Analysis (Population Mean Cosinor) for Intervention Group (IG) and Control Group (CG) at Baseline 





(Mean and 95% CL)
Acrophase (h:min)  
(Mean and 95% CL)
IG (N = 19) PRE 232.9 ± 18.1 197.8 (167.4-228.1) 14:52 (12:30-17:14)
 POST 221.9 ± 10.8 177.9 (164.8-191) 15:00 (12:45-17:15)
CG (N = 21) PRE 223.7 ± 14.5 197.2 (177.5-216.8) 14:31 (12:23-16:39)
 POST 215.8 ± 9.5 179.6 (166.1-193.1) 14:47 (12:32-17:02)
Abbreviation: CL, confidence limit.
aThe table reports results of the actigraphy-based analysis of the activity-level circadian rhythmicity in the IG and CG at baseline (PRE) and after 3 
months (POST). The population mean cosinor applied to IG and CG at PRE and POST revealed the presence of a significant circadian rhythm in the 
2 groups (P < .001). MESOR, Amplitude, and Acrophase were not different in the 2 groups in pretest conditions. Amplitude decreased significantly 
between PRE and POST (F[1, 38] = 6.4, P = .02). MESOR and Acrophase remained unchanged.
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Discussion
The major finding of this study was that a 3-month program 
of aerobic PA, performed twice a week, exerted a protective 
effect on the sleep behavior of women with BC. While in 
most of the previous studies sleep disturbances in women 
with BC were measured by using questionnaires, in the 
present study we have used actigraphic monitoring to eval-
uate sleep patterns at baseline and at the end of 3 months of 
PA program. The actigraph-based monitoring is certainly a 
more objective method in order to evaluate the effect of the 
exercise intervention on sleep scores.
Under baseline conditions, IG and CG patients showed 
virtually superimposable sleep behaviors with comparable 
actigraphy-based sleep parameters. After 3 months, IG and 
CG patients showed differential changes in sleep behavior, 
as documented by the results of the RM-MANOVA (applied 
to parameters AST, SE, MAS, MFI) and by the results of the 
parametric univariate analysis (applied to parameter AWT) 
and nonparametric univariate analysis (applied to parame-
ters SL and IT). While CG patients showed a generalized 
deterioration of sleep behavior, IG patients showed a more 
stable pattern. In the CG group, all of the 7 sleep parameters 
displayed significant changes from PRE to POST that could 
be interpreted as a deterioration of sleep quality, since it was 
seen that the 3 Restful Sleep Parameters (SE, AST, IT) 
decreased and the 4 Sleep Fragmentation Parameters (AWT, 
SL, MAS, MFI) increased. In contrast, in the IG group, 5 
out of 7 sleep parameters (SE, IT, AWT, SL, MAS) mea-
sured at the end of the PA program showed no changes with 
respect to the baseline assessment. Of note is that the 2 
parameters (AST and MFI) whose patterns of change were 
not significantly different in the 2 groups across the 2 time 
points showed a less pronounced change in the IG than in 
the CG (see Table 1 and Figure 1).
Payne et al,27 who evaluated the efficacy of a prescribed 
home-based walking intervention on sleep disturbances by 
actigraphy, found significant differences between an exer-
cise group and usual care group in Actual Wake Time and 
Actual Sleep Time. Less movement during sleep also was 
noted in the exercise group, suggesting that a walking exer-
cise intervention improves sleep in women receiving hor-
monal treatment for BC, although the authors did not find 
significant modification of SE, perhaps due to the small 
sample size and subsequent limited power. Instead, in our 
study the sample is twice as big compared to the study of 
Payne and colleagues.
In this study we decided not to include subjective sleep 
evaluations because the questionnaires usually refer to a 
longer period of nocturnal rest (eg, the Pittsburgh Sleep 
Quality Index is a 19-item self-report scale that measures 
sleep quality over the past month),40 and we preferred to 
analyze only 1 week with the actigraphs to be more accu-
rate and objective, especially when evaluating the effects 
of the aerobic PA in the IG. The marked worsening in sleep 
parameters of CG patients was unexpected and the reasons 
for this outcome are unclear. It stands to reason that this 
may be due to seasonal environmental modifications, pos-
sibly interacting with the underlying disease of these 
women. However, since a healthy control group of the 
same sex and age was not included in our study, the indi-
vidual contribution of the above-mentioned factors cannot 
be elucidated from our data.
No clinical or pathological modification occurred in CG 
that could justify the sleep worsening during the trial, since 
all CG women maintained good health without pathological 
BC complications. In the following, we will limit ourselves 
to speculate about the likely environmental factors that, 
based on the existing literature, might have affected the 
Table 3. Anthropometric and Motion-Level Data at Baseline (PRE) and After 3 Months (POST) for Intervention Group (IG) Versus 
Control Group (CG)a.
Parameters
IG (N = 19) CG (N = 21)
PRE POST P PRE POST P
Weight (kg) 67.1 ± 11.9 66.6 ± 11.8 .03 64.5 ± 9.6 63.7 ± 9.5 .01
BMI (kg/m2) 25.4 ± 3.8 25.2 ± 3.7 .04 24.6 ± 3.4 24.3 ± 3.4 .01
Waist circumference (cm) 80.5 ± 11.0 79.8 ± 10.0 .04 80.3 ± 8.7 80.1 ± 9.1 ns
Fat mass (%) 33.7 ± 5.5 31.7 ± 6.6 .02 33.2 ± 6.2 32.7 ± 5.5 ns
Lean mass (%) 66.4 ± 5.4 68.2 ± 6.2 .04 66.8 ± 6.2 67.9 ± 5.5 ns
TEE (kcal) 2058.0 ± 180.9 2111.7 ± 222.2 ns 2123.0 ± 222.3 2113.7 ± 213.3 ns
Number of steps 9790.9 ± 2817.2 11071.1 ± 3520.9 .04 11001.6 ± 3702.2 11672 ± 3981.2 ns
METs average 1.32 ± 0.14 1.42 ± 0.17 .04 1.41 ± 0.18 1.43 ± 0.17 ns
PAL 1.49 ± 0.10 1.55 ± 0.12 ns 1.56 ± 0.14 1.57 ± 0.13 ns
Abbreviations: BMI, body mass index; TEE, total energy expenditure; PAL, physical activity level.
aValues presented as mean ± SD. The comparisons between IG and CG, both PRE and POST, did not show any statistical difference. Statistical 
significance is fixed at P < .025 (Bonferroni correction). The anthropometric and motion-level parameters’ comparison between IG and CG in baseline 
condition and after 3 months showed no significant difference.
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sleep of the 2 groups. Sleep modifications could be related 
to the day length, seasonal adaptation, and the Daylight 
Saving Time (DST) transition. It is well known that sea-
sonal changes in morning light and especially sunrise 
times41,42 can affect sleep behavior. Specifically, in a study 
carried out in the European population, Kantermann et al42 
found seasonal fluctuations in sleep duration, with about 20 
minutes less sleep in summer than in winter. In our study, 
we carried out the first sleep monitoring (the baseline con-
dition) in the last week of February and the second monitor-
ing (the final condition) in the first week of June, that is, 
close to the transition from spring to summer. Interestingly, 
from February to June, the AST in the CG decreased of 
about 28 minutes, a figure consistent with the findings of 
Kantermann and coworkers.
It is also well documented that seasonal variations in 
ambient temperature can influence the circadian rhythm 
and sleep quality. For instance, Haskell et al43 suggested 
that the wakefulness and the worsening of sleep are typical 
effects of heat exposure conditions. Some other studies43-45 
have pointed out that poor sleep and fatigue are associated 
with the increase of ambient temperature in hot seasons. In 
our study, the mean ambient temperature in Milan changed 
from 7.1°C in February to 22.6°C in June 2014 (source: 
Meteorological Weather Forecast, Italian Military Aviation). 
Such a marked increase in ambient temperature might have 
contributed to the sleep deterioration observed in the CG.
The seasonal and DST transition are additional factors 
that might have played a role in the sleep deterioration 
observed in the CG. The DST transition occurred on the last 
Sunday of March and produced an abrupt increase in the 
available daylight in the evening. Disrupted night-sleep is 
one of the main DST consequences. Several studies41,46,47 
have shown that the spring transition can compromise sleep 
by reducing both sleep duration and sleep efficiency. For 
instance, Kantermann et al42 reported that the spring transi-
tion induces, in healthy subjects, a reduction of sleep dura-
tion for 8 consecutive weeks following the transition. In our 
study, the second sleep monitoring was carried out in the 
first week of June, and thus slightly beyond the interval 
investigated by Kantermann and colleagues.42 Although it is 
not unreasonable to hypothesize that the second sleep moni-
toring was influenced by the seasonal change and the DST 
transition, this only remains a matter of speculation. Another 
consideration is that sleep behavior3 and DST adaptation48 
are chronotype specific. Allebrandt et al48 showed that the 
evening-types have a shorter sleep during the DST transi-
tion. It would have been interesting to evaluate the CG sleep 
worsening also in relation to the chronotypes, but we did 
not assess the circadian typology of the subjects.
All in all, we purport that the CG group experienced a 
difficult adjustment to the above-mentioned environmental 
changes, leading to a deterioration of sleep parameters. 
Since the IG patients were exposed to the same disruption 
as the CG patients, one reasonable explanation for the sub-
stantial stability of their sleep behavior is that the PA pro-
gram counteracted the worsening effect of the environmental 
and seasonal factors.
It is worth making some specific comments about the 
changes of parameter SE since it is probably the most 
widely used parameter to summarize the sleep quality of an 
individual. In CG patients, SE decreased from 84.6% to 
80.7%. In contrast, in IG patients SE moved from 84.4% to 
86.4%. Since SE = 85% is considered the clinical cutoff for 
clinically significant sleep disruption,49 these results seem 
to suggest that IG patients were able to maintain their SE 
just above the cutoff, whereas CG patients exhibited almost 
a 5% drop of SE below the cutoff. It is worth emphasizing 
that BC women having SE > 85% have been shown to have 
lower mortality50 and that sleep quality is positively related 
to quality of life in cancer patients.8 If, however, we make a 
comparison with sleep parameters proposed by Natale and 
colleagues51 who fixed the cutoff value for sleep efficiency 
(low sensitivity) at 87%, neither the IG nor the CG achieve 
a good sleep quality.
Thus, the ability of PA to preserve SE warrants further 
investigation because this ability may have some potential 
in prolonging life and improving well-being of BC 
survivors.52 Referring to activity-level circadian rhythm, we 
could observe a substantially stability in the circadian 
rhythm parameters; MESOR and Acrophase were the same 
in the 2 groups and remained unchanged across time.
Taking into consideration the anthropometric and body 
composition parameters, we observed changes in both the 
CG and IG. At baseline, all women had similar parameters, 
so they started to join the project with the same physical 
characteristics. After 3 months IG decreased significantly 
the percentage of fat mass and tended to increase the lean 
mass but not significantly. Therefore, the improvement of 
these parameters confirms, as reported in the literature,18,20 
that PA program is able to modify risk factors related to BC 
prognosis.
These results in the IG are due to the PA program, and we 
hypothesized that the improvements for the CG in BMI and 
body weight is partly due to the diet that the women are fol-
lowing. In fact, women included in this study were extracted 
from the group of a dietary intervention trial (DIANA-5), so 
some positive changes could be influenced by the effect of 
diet and by the baseline recommendation to be physically 
active; this clearly appears in CG for the positive changes of 
anthropometric parameters. After 3 months neither IG nor 
CG modified any motion-level parameter.
Conclusion
The results of the present study suggest that aerobic PA has 
a protective effect against factors promoting sleep disrup-
tion. PA is an integrative intervention therapy that has the 
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potential to render sleep behavior less sensitive to detrimen-
tal environmental factors.
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